J Biol Chem 2001, 276:13427–13432.PubMedCrossRef 14. Lei Selleck Repotrectinib X, Bai Z, Ye F, Xie J, Kim CG, Huang Y, Gao SJ: Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 2010, 12:193–199.PubMedCrossRef 15. Finbloom DS, Winestock KD: IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 1995,

155:1079–1090.PubMed 16. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD: Interleukin-4 and interleukin-13 signaling connections maps. Science 2003, 300:1527–1528.PubMedCrossRef 17. Deng J, Hua K, Lesser SS, Greiner AH, Walter AW, Marrero MB, Harp JB: Interleukin-4 mediates STAT6 activation in 3T3-L1 preadipocytes but not adipocytes. Biochem Biophys Res Commun 2000, 267:516–520.PubMedCrossRef 18. Grehan JF, Levay-Young BK, Fogelson JL, Francois-Bongarcon V, Benson BA, Dalmasso AP: IL-4 and IL-13 induce protection of porcine endothelial cells from killing by human complement and from apoptosis through activation of

a phosphatidylinositide 3-kinase/Akt pathway. J Immunol 2005, 175:1903–1910.PubMed 19. Crawley JB, Williams LM, Mander T, Brennan FM, Foxwell BM: Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine. J Biol Chem 1996, 271:16357–16362.PubMedCrossRef 20. Zhou JH, Broussard SR, Strle K, Freund this website GG, Johnson RW, Dantzer R, Kelley KW: IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3′-kinase. J Immunol 2001, 167:4436–4442.PubMed 21. Ip WK, Wong CK, Lam CW: Interleukin (IL)-4 and IL-13 up-regulate monocyte

chemoattractant protein-1 expression in human bronchial epithelial cells: eFT508 involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways. Clin Exp Immunol 2006, 145:162–172.PubMedCrossRef 22. David M, Ford D, Bertoglio J, Maizel AL, Pierre J: Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Adenylyl cyclase Oncogene 2001, 20:6660–6668.PubMedCrossRef 23. Wang L, Damania B: Kaposi’s sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res 2008, 68:4640–4648.PubMedCrossRef 24. Sharma-Walia N, Krishnan HH, Naranatt PP, Zeng L, Smith MS, Chandran B: ERK1/2 and MEK1/2 induced by Kaposi’s sarcoma-associated herpesvirus (human herpesvirus early during infection of target cells are essential for expression of viral genes and for establishment of infection. J Virol 2005, 79:10308–10329.PubMedCrossRef 25.